Neurocrine Biosciences (NBIX) Intangibles (2022 - 2026)
Neurocrine Biosciences (NBIX) posted quarterly Intangibles of $2.2 billion for Q2 2026, up 5883.87% year-over-year from $37.2 million in Q2 2025, and up 47261.7% on a QoQ basis from $4.7 million in Q4 2025.
Neurocrine Biosciences (NBIX) Intangibles (2022 - 2026) Analysis & Trends
Neurocrine Biosciences has reported Intangibles for 5 years, with the latest figure at $2.2 billion in Q2 2026.
- Intangibles for Q2 2026 came in at $2.2 billion, up 5883.87% year-over-year; the trailing twelve-month figure through Jun 2026 was $2.2 billion (up 5883.87% YoY), and the FY2025 annual result was $4.7 million, down 87.12% from the prior year.
- Intangibles grew to $2.2 billion in Q2 2026, from $4.7 million in the prior quarter.
- Over five years, Intangibles peaked at $2.2 billion in Q2 2026 and troughed at $4.7 million in Q4 2025.
- A 5-year average of $190.0 million and a median of $36.0 million in 2025 frame the typical range for Intangibles.
- The widest annual swing landed in 2025, when Intangibles plunged 87.12%; it then surged 5883.87% in 2026.
- A 5-year view of Intangibles shows it stood at $37.2 million in 2022, then retreated by 4.57% to $35.5 million in 2023, then gained by 2.82% to $36.5 million in 2024, then plunged by 87.12% to $4.7 million in 2025, then jumped by 47261.7% to $2.2 billion in 2026.
- Per Business Quant data, the three most recent Intangibles figures were $2.2 billion in Q2 2026, $4.7 million in Q4 2025, and $35.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 1.12 Bn |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | 1.80 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.23 Bn |
| Dec 31, 2025 | 4.70 Mn |
| Sep 30, 2025 | 35.70 Mn |
| Jun 30, 2025 | 37.20 Mn |
| Mar 31, 2025 | 36.40 Mn |
| Dec 31, 2024 | 36.50 Mn |
| Sep 30, 2024 | 34.50 Mn |
| Jun 30, 2024 | 33.50 Mn |
| Mar 31, 2024 | 34.30 Mn |
| Dec 31, 2023 | 35.50 Mn |
| Sep 30, 2023 | 34.90 Mn |
| Jun 30, 2023 | 36.90 Mn |
| Mar 31, 2023 | 37.20 Mn |
| Dec 31, 2022 | 37.20 Mn |